Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (108)
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
8,003
Price
$4.80
Total Value
$38.41K
Shares Held After
722,419
% of Holdings
1.1%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
25,000
Price
$4.98
Total Value
$124.54K
Shares Held After
714,416
% of Holdings
3.5%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
3,300
Price
$4.98
Total Value
$16.42K
Shares Held After
689,416
% of Holdings
0.5%
ProQR Therapeutics N.V. (PRQR)
de Boer Daniel Anton — Director
Shares
200,000
Price
$1.77
Total Value
$353.96K
Shares Held After
500,000
% of Holdings
40.0%
Anixa Biosciences Inc (ANIX)
KUMAR AMIT — Director
Shares
5,000
Price
$3.47
Total Value
$17.35K
Shares Held After
657,000
% of Holdings
0.8%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
24,944
Price
$9.93
Total Value
$247.69K
Shares Held After
17,329,570
% of Holdings
0.1%
IONIS PHARMACEUTICALS INC (IONS)
Hayden Michael R — Director
Shares
5,000
Price
$51.60
Total Value
$258.00K
Shares Held After
24,000
% of Holdings
20.8%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
77,850
Price
$4.96
Total Value
$385.79K
Shares Held After
686,116
% of Holdings
11.3%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
100,000
Price
$4.90
Total Value
$490.00K
Shares Held After
608,266
% of Holdings
16.4%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
25,000
Price
$4.81
Total Value
$120.34K
Shares Held After
508,266
% of Holdings
4.9%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
20,000
Price
$5.00
Total Value
$100.00K
Shares Held After
483,266
% of Holdings
4.1%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
20,000
Price
$5.00
Total Value
$100.00K
Shares Held After
463,266
% of Holdings
4.3%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
50,000
Price
$4.97
Total Value
$248.62K
Shares Held After
443,266
% of Holdings
11.3%
Protagenic Therapeutics, Inc.\new (PTIX)
ARMEN GARO H — Director
Shares
26,291
Price
$0.18
Total Value
$4.81K
Shares Held After
26,291
% of Holdings
100.0%
IONIS PHARMACEUTICALS INC (IONS)
Hayden Michael R — Director
Shares
15,000
Price
$53.38
Total Value
$800.70K
Shares Held After
19,000
% of Holdings
78.9%
MapLight Therapeutics, Inc. (MLPT)
Catalyst4, Inc. — 10% Owner
Shares
1,000,000
Price
$13.00
Total Value
$13.00M
Shares Held After
20,906,689
% of Holdings
4.8%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
20,824
Price
$9.99
Total Value
$208.03K
Shares Held After
17,304,626
% of Holdings
0.1%
HCW Biologics Inc. (HCWB)
GARRETT SCOTT T — Director
Shares
7,736
Price
$2.58
Total Value
$20.00K
Shares Held After
41,644
% of Holdings
18.6%
HCW Biologics Inc. (HCWB)
Wong Hing C — Director
Shares
23,210
Price
$2.58
Total Value
$60.00K
Shares Held After
125,845
% of Holdings
18.4%
HCW Biologics Inc. (HCWB)
Flowers Lee — SVP of Business Development
Shares
7,736
Price
$2.58
Total Value
$20.00K
Shares Held After
8,691
% of Holdings
89.0%
MapLight Therapeutics, Inc. (MLPT)
Catalyst4, Inc. — 10% Owner
Shares
3,000
Price
$12.63
Total Value
$37.89K
Shares Held After
19,906,689
% of Holdings
0.0%
Greenwich LifeSciences, Inc. (GLSI)
Patel Snehal — Director
Shares
700
Price
$13.10
Total Value
$9.17K
Shares Held After
5,611,402
% of Holdings
0.0%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,000
Price
$0.78
Total Value
$3.90K
Shares Held After
373,885
% of Holdings
1.3%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
1,600
Price
$5.00
Total Value
$8.00K
Shares Held After
393,266
% of Holdings
0.4%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
1,810
Price
$5.00
Total Value
$9.05K
Shares Held After
391,666
% of Holdings
0.5%
Outlook Therapeutics, Inc. (OTLK)
Sukhtian Faisal Ghiath — Director
Shares
95,398
Price
$1.05
Total Value
$100.00K
Shares Held After
220,972
% of Holdings
43.2%
MapLight Therapeutics, Inc. (MLPT)
Catalyst4, Inc. — 10% Owner
Shares
65,137
Price
$11.69
Total Value
$761.39K
Shares Held After
19,903,689
% of Holdings
0.3%
MapLight Therapeutics, Inc. (MLPT)
Catalyst4, Inc. — 10% Owner
Shares
141,088
Price
$10.74
Total Value
$1.52M
Shares Held After
19,838,552
% of Holdings
0.7%
Greenwich LifeSciences, Inc. (GLSI)
Patel Snehal — Director
Shares
1,500
Price
$13.59
Total Value
$20.39K
Shares Held After
5,610,702
% of Holdings
0.0%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
6,400
Price
$4.95
Total Value
$31.68K
Shares Held After
389,856
% of Holdings
1.6%
MapLight Therapeutics, Inc. (MLPT)
Cox Troy — Director
Shares
15,620
Price
$9.52
Total Value
$148.70K
Shares Held After
15,620
% of Holdings
100.0%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
7,798
Price
$5.00
Total Value
$38.99K
Shares Held After
383,456
% of Holdings
2.0%
Greenwich LifeSciences, Inc. (GLSI)
Patel Snehal — Director
Shares
1,500
Price
$13.62
Total Value
$20.43K
Shares Held After
5,609,202
% of Holdings
0.0%
Anixa Biosciences Inc (ANIX)
KUMAR AMIT — Director
Shares
5,000
Price
$3.44
Total Value
$17.20K
Shares Held After
652,000
% of Holdings
0.8%
Anixa Biosciences Inc (ANIX)
KUMAR AMIT — Director
Shares
3,188
Price
$3.37
Total Value
$10.74K
Shares Held After
647,000
% of Holdings
0.5%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
41,319
Price
$9.99
Total Value
$412.78K
Shares Held After
17,283,802
% of Holdings
0.2%
Anixa Biosciences Inc (ANIX)
KUMAR AMIT — Director
Shares
3,000
Price
$3.73
Total Value
$11.19K
Shares Held After
643,812
% of Holdings
0.5%
Greenwich LifeSciences, Inc. (GLSI)
Patel Snehal — Director
Shares
1,100
Price
$12.88
Total Value
$14.17K
Shares Held After
5,607,702
% of Holdings
0.0%
Greenwich LifeSciences, Inc. (GLSI)
Patel Snehal — Director
Shares
2,500
Price
$13.14
Total Value
$32.85K
Shares Held After
5,606,602
% of Holdings
0.0%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
59,880
Price
$9.96
Total Value
$596.40K
Shares Held After
17,242,483
% of Holdings
0.3%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
84,124
Price
$9.93
Total Value
$835.35K
Shares Held After
17,182,603
% of Holdings
0.5%
Greenland Mines Ltd (GRML)
Sawyer Jason David — Director
Shares
240,000
Price
$0.23
Total Value
$55.94K
Shares Held After
240,000
% of Holdings
100.0%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
120,582
Price
$9.55
Total Value
$1.15M
Shares Held After
17,098,479
% of Holdings
0.7%
Rani Therapeutics Holdings, Inc. (RANI)
IMRAN MIR A — Director
Shares
36,000
Price
$0.69
Total Value
$24.84K
Shares Held After
2,119,334
% of Holdings
1.7%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
2,975
Price
$2.44
Total Value
$7.26K
Shares Held After
2,858,935
% of Holdings
0.1%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
1,623
Price
$2.44
Total Value
$3.96K
Shares Held After
2,855,960
% of Holdings
0.1%
Anixa Biosciences Inc (ANIX)
KUMAR AMIT — Director
Shares
5,000
Price
$3.46
Total Value
$17.30K
Shares Held After
640,812
% of Holdings
0.8%
Anixa Biosciences Inc (ANIX)
Titterton Lewis H jr — Director
Shares
12,000
Price
$3.47
Total Value
$41.64K
Shares Held After
986,967
% of Holdings
1.2%
Greenland Mines Ltd (GRML)
McGarity Jon — Director
Shares
140,000
Price
$0.18
Total Value
$24.82K
Shares Held After
551,277
% of Holdings
25.4%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
265
Price
$2.44
Total Value
$646.60
Shares Held After
2,854,337
% of Holdings
0.0%
Showing 1–50 of 108 transactions (page 1 of 3)